Mobilization of hematopoietic progenitor cells with paclitaxel (taxol) as a single chemotheraupetic agent, associated with rhG-CSF

Bone Marrow Transplantation

Volumn 25, Issue 3, 2000, Pages 231-235

  Gomez Espuch J ^a   Moraleda Jimenez J M ^a,b   Ortuno F ^a   Lozano, M L ^a   Ayala, F ^a   Vallejo, C ^a   De Arriba, F ^a   Vicente, V ^a  

^a HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b HOSPITAL UNIVERSITARIO MORALES MESEGUER   (Spain)

Author keywords

CD34; Leukapheresis; Mobilization; Taxanes

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; PACLITAXEL;

ADULT; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; FEMALE; HUMAN; LEUKAPHERESIS; NEUTROPENIA; PRIORITY JOURNAL;

EID: 0342680002     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702130     Document Type: Article

References (17)

1. Bensinger W, Appelbaum F, Rowley S et al. Factors that influence collection and engraftment of autologous peripheral blood stem cells. J Clin Oncol 1995; 13: 2547-2555.
2. Eisenhauer EA, Vermorken JB. The taxoids. Comparative clinical pharmacology and therapeutic potential. Drugs 1998; 55: 5-30.
3. Demirer T, Rowley S, Buckner D et al. Peripheral blood stem cell collection after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer. J Clin Oncol 1995; 13: 1714-1719.
4. Shea TC. Mobilization of peripheral blood progenitor cells with paclitaxel-based chemotherapy. Semin Oncol 1997; 24 (Suppl. 2): 105-107.
5. Weaver CH, Schwartzberg LS, Birch R et al. Collection of peripheral blood stem cells following administration of paclitaxel, cyclophosphamide, and filgrastim in patients with breast and ovarian cancer. Biol Blood Marrow Transplant 1997; 3: 83-90.
6. Pedrazzoli P, Perotti C, Da Prada GA et al. Collection of circulating progenitor cells after epirubicin, paclitaxel and filgrastim in patients with metastatic breast cancer. Br J Cancer 1997; 75: 1368-1372.
7. Bengala C, Pazzagli Y, Tibaldi C et al. Mobilization, collection, and characterisation of peripheral blood hematopoietic progenitors after chemotherapy with epirubicin, paclitaxel and granulocyte-colony stimulating factor administered to patients with metastatic breast carcinoma. Cancer 1998; 85: 867-873.
8. Demirer T, Buckner CD, Storer B et al. Effect of different chemotherapy regimens on peripheral-blood stem cell collection in patients with breast cancer receiving granulocyte colony stimulating factor. J Clin Oncol 1997; 15: 684-690.
9. De Arriba F, Lozano ML, Ortuño F et al. Prospective randomised study comparing the efficacy of bioequivalent doses of glycosylated and nonglycosylated rhG-CSF for mobilizing peripheral blood progenitor cells. Br J Haematol 1997; 96: 418-420.
10. + cells in bone marrow and peripheral blood of patients after chemotherapy and GM-CSF. Exp Haematol 1993; 21: 1163-1166.
11. Burtness BA, Psyrri A, Rose M et al. A phase I study of paclitaxel for mobilization of peripheral blood progenitor cells. Bone Marrow Transplant 1999; 23: 311-315.
12. + cells effectively. Proc Am Soc Clin Oncol 1995; 14: 108 (Abstr.).
13. + cell transplantation. Blood 1995; 86 (Suppl. 1): 405a.
14. + counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation. Blood 1998; 9: 3148-3155.
15. Olivieri A, Offidani M, Montarani M et al. Factors affecting hematopietic recovery after high dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience. Haematologica 1998; 83: 329-337.
16. + cell content. Bone Marrow Transplant 1997; 19: 1103-1110.
17. Schwella N, Beyer I, Schwaner I et al. Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer. J Clin Oncol 1996; 14: 1114-1121.